Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Strategies to safeguard psychiatric units in general hospitals: Overcoming closure risks for community support.
Funayama M, Maruyama F, Nohara S, Satake N, Sato S, Koishikawa H, Wada K, Hasegawa Y, Kato O, Akahane T, Wada H, Tsujino N, Noguchi M, Takata T, Nishimura K. Funayama M, et al. Among authors: nishimura k. Gen Hosp Psychiatry. 2025 Jan 31;93:100-102. doi: 10.1016/j.genhosppsych.2025.01.014. Online ahead of print. Gen Hosp Psychiatry. 2025. PMID: 39893865 No abstract available.
Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC.
Tohi Y, Kobayashi K, Daizumoto K, Sekino Y, Fukuhara H, Niigawa H, Katayama S, Shimizu R, Takamoto A, Nishimura K, Nagami T, Hayashida Y, Hirama H, Shiraishi K, Tomida R, Kobatake K, Inoue K, Miyaji Y, Bekku K, Morizane S, Miura N, Wada K, Sugimoto M; Chu-shikoku Japan Urological Consortium. Tohi Y, et al. Among authors: nishimura k. Jpn J Clin Oncol. 2025 Feb 2:hyaf025. doi: 10.1093/jjco/hyaf025. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39893578
Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: nishimura k. Int J Clin Oncol. 2025 Jan 31. doi: 10.1007/s10147-025-02709-1. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39890750
4,241 results